STAT3 inhibitors suppress STAT3 activation, down-regulate HIF-1α expression, and up-regulate the radiosensitivity of esophageal squamous cell carcinoma (ESCC) in vivo and in vitro [200]. This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.